Literature DB >> 26722454

Association of miRNA-145 expression in vascular smooth muscle cells with vascular damages in patients with lupus nephritis.

Yan Ding1, Wang Liao2, Zhuwen Yi3, Wei Xiang4, Xiaojie He3.   

Abstract

miRNAs have been found to contribute to the regulation of multiple cellular processes, including cell apoptosis, differentiation and proliferation. The patients with lupus nephritis (LN) exhibit thickened renal vascular membrane and highly proliferative vascular smooth muscle cells (VSMCs). Of various miRNAs discovered, miR-145 is essential to mediate the proliferation of VSMCs and the formation of atherosclerotic plaques. In this study, we studied the pathological and vascular damage of renal LN, and the correlation between miR-145 expression in VSMCs and the vascular damages. Serum, urine, and renal biopsies were obtained from 41 patients with active LN. The serum and urinary VEGF levels were examined to confirm the renal damage of each patient. Biopsies were stained to observe the glomerular segmental lesions, sclerosis, and to evaluate the vascular damages. The expression of miR-145 was also examined to determine the correlation between its expression and the vascular damages. The expression of miR-145 was mainly detected in the renal VSMCs and the epithelial cells of glomerular proximal convoluted tubule. Nevertheless, the expression of miR-145 reduced as the tunicae media vasorum ratios increased, indicating the development of LN inhibits the expression of miR-145. Furthermore, our studies revealed no significant correlation among renal interstitial vascular damage, glomerular damage and severity classification of LN. Therefore, we suggest the damage of renal interstitial vascular should be considered as one of the factors to evaluate the severity of the LN.

Entities:  

Keywords:  lupus nephritis; miR-145; renal interstitial vascular

Mesh:

Substances:

Year:  2015        PMID: 26722454      PMCID: PMC4680399     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  29 in total

1.  Renal vascular complications of systemic lupus erythematosus.

Authors:  G B Appel; C L Pirani; V D'Agati
Journal:  J Am Soc Nephrol       Date:  1994-02       Impact factor: 10.121

Review 2.  Lupus nephritis in children.

Authors:  F Perfumo; A Martini
Journal:  Lupus       Date:  2005       Impact factor: 2.911

3.  Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation.

Authors:  R Katafuchi; Y Kiyoshi; Y Oh; N Uesugi; K Ikeda; T Yanase; S Fujimi
Journal:  Clin Nephrol       Date:  1998-01       Impact factor: 0.975

4.  Renal vascular lesions in lupus nephritis.

Authors:  E Descombes; D Droz; L Drouet; J P Grünfeld; P Lesavre
Journal:  Medicine (Baltimore)       Date:  1997-09       Impact factor: 1.889

5.  Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long-term renal survival.

Authors:  F Bridoux; F Vrtovsnik; C Noël; P Saunier; B Mougenot; V Lemaitre; M Dracon; G Lelièvre; P Vanhille
Journal:  Nephrol Dial Transplant       Date:  1998-02       Impact factor: 5.992

6.  Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis.

Authors:  Yingyos Avihingsanon; Thitima Benjachat; Adis Tassanarong; Pimpayao Sodsai; Vipawee Kittikovit; Nattiya Hirankarn
Journal:  Kidney Int       Date:  2009-03-18       Impact factor: 10.612

7.  Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII).

Authors:  L B Tucker; A G Uribe; M Fernández; L M Vilá; G McGwin; M Apte; B J Fessler; H M Bastian; J D Reveille; G S Alarcón
Journal:  Lupus       Date:  2008-04       Impact factor: 2.911

8.  Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.

Authors:  Hermine I Brunner; Dafna D Gladman; Dominique Ibañez; Murray D Urowitz; Earl D Silverman
Journal:  Arthritis Rheum       Date:  2008-02

9.  MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.

Authors:  Yunhui Cheng; Xiaojun Liu; Jian Yang; Ying Lin; Da-Zhong Xu; Qi Lu; Edwin A Deitch; Yuqing Huo; Ellise S Delphin; Chunxiang Zhang
Journal:  Circ Res       Date:  2009-06-18       Impact factor: 17.367

Review 10.  MicroRNA in autoimmunity and autoimmune diseases.

Authors:  Kaleb M Pauley; Seunghee Cha; Edward K L Chan
Journal:  J Autoimmun       Date:  2009-03-19       Impact factor: 7.094

View more
  3 in total

Review 1.  Renal microvascular lesions in lupus nephritis.

Authors:  Ying Ding; Ying Tan; Zhen Qu; Feng Yu
Journal:  Ren Fail       Date:  2019-12-20       Impact factor: 2.606

2.  Type I Interferon Dependent hsa-miR-145-5p Downregulation Modulates MUC1 and TLR4 Overexpression in Salivary Glands From Sjögren's Syndrome Patients.

Authors:  Daniela Jara; Patricia Carvajal; Isabel Castro; María-José Barrera; Sergio Aguilera; Sergio González; Claudio Molina; Marcela Hermoso; María-Julieta González
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

3.  Investigation of MicroRNA in Mitochondrial Apoptotic Pathway in Systemic Lupus Erythematosus.

Authors:  Yu-Jih Su; Nai-Wen Tsai; Chia-Te Kung; Hung-Chen Wang; Wei-Che Lin; Chih-Cheng Huang; Ya-Ting Chang; Chih-Min Su; Yi-Fang Chiang; Ben-Chung Cheng; Yu-Jun Lin; Cheng-Hsien Lu
Journal:  Biomed Res Int       Date:  2018-07-10       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.